MedTrace Logo

Measurement of Circulating Cell-free DNA (cfDNA) for Diagnosis and Prognosis of Various Diseases and Evaluation of Tissue Damage

NCT05094960 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2021-11-05

No results posted yet for this study

Summary

To characterize the changes in circulating cell-free DNA (cfDNA) levels during cardiopulmonary bypass (CPB) and to access their association with outcomes compared to standard scores.

Conditions

  • Correlation of cFDNA During CPB to Laboratories SIRS Parameters and Clinical Outcomes

Interventions

DIAGNOSTIC_TEST

Blood samples

5 blood samples for each patient during CABG (coronary artery bypass grafting) surgery pre/on/post cardiopulmonary bypass machine

Sponsors & Collaborators

  • Soroka University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-30
Primary Completion
2011-03-22
Completion
2021-07-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05094960 on ClinicalTrials.gov